Research ExplorerJournalsCLIN CANCER RES Publications

CLIN CANCER RES

101 - 126 out of 126Page size: 50

Publications

  1. 2007

  2. Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91.

    Rutkowski, S., von Bueren, A., von Hoff, K., Hartmann, W., Shalaby, T., Deinlein, F., Warmuth-Metz, M., Soerensen, N., Emser, A., Udo, B., Mittler, U., Urban, C., Benesch, M., Kortmann, R. D., Schlegel, P. G., Kuehl, J., Pietsch, T. & Grotzer, M., 2007, In: CLIN CANCER RES. 13, 9, p. 2651-2657 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. The graft content of donor T cells expressing gamma delta TCR+ and CD4+foxp3+ predicts the risk of acute graft versus host disease after transplantation of allogeneic peripheral blood stem cells from unrelated donors.

    Pabst, C., Schirutschke, H., Ehninger, G., Bornhäuser, M. & Platzbecker, U., 2007, In: CLIN CANCER RES. 13, 10, p. 2916-2922 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. 2006

  5. Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer

    Borgoño, C. A., Kishi, T., Scorilas, A., Harbeck, N., Dorn, J., Schmalfeldt, B., Schmitt, M. & Diamandis, E. P., 01.03.2006, In: CLIN CANCER RES. 12, 5, p. 1487-93 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. A multimarker model to predict outcome in tamoxifen-treated breast cancer patients.

    Linke, S. P., Bremer, T. M., Herold, C. D., Sauter, G. & Diamond, C., 2006, In: CLIN CANCER RES. 12, 4, p. 1175-1183 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. A novel one-armed anti-c-Met antibody inhibits glioblastoma growth in vivo.

    Martens, T., Schmidt, N-O., Eckerich, C., Fillbrandt, R., Merchant, M., Schwall, R., Westphal, M. & Lamszus, K., 2006, In: CLIN CANCER RES. 12(20 Pt 1), p. 6144-6152

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Characterization and expression of CT45 in Hodgkin's lymphoma.

    Heidebrecht, H-J., Claviez, A., Kruse, M. L., Pollmann, M., Buck, F., Harder, S., Tiemann, M., Dörffel, W. & Parwaresch, R., 2006, In: CLIN CANCER RES. 12, 16, p. 4804-4811 16.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. In vitro drug sensitivity predicts response and survival after individualized sensitivity-directed chemotherapy in metastatic melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group.

    Ugurel, S., Schadendorf, D., Pföhler, C., Neuber, K., Thoelke, A., Ulrich, J., Hauschild, A., Spieth, K., Kaatz, M., Rittgen, W., Delorme, S., Tilgen, W. & Reinhold, U., 2006, In: CLIN CANCER RES. 12, 18, p. 5454-5463 18.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Microsatellite DNA alterations of gastrointestinal stromal tumors are predictive for outcome.

    Schurr, P., Wolter, S., Kaifi, J., Reichelt, U., Kleinhans, H., Wachowiak, R., Yekebas, E., Strate, T., Kalinin, V., Simon, R., Sauter, G., Schaefer, H. & Izbicki, J., 2006, In: CLIN CANCER RES. 12, 17, p. 5151-5157 17.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Prognostic and predictive effects of immunohistochemical factors in high-risk primary breast cancer patients.

    Kröger, N., Milde-Langosch, K., Riethdorf, S., Schmoor, C., Schumacher, M., Zander, A. R. & Löning, T., 2006, In: CLIN CANCER RES. 12, 1, p. 159-168 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications.

    Christoph, F., Weikert, S., Kempkensteffen, C., Krause, H., Schostak, M., Köllermann, J., Miller, K. & Schrader, M., 2006, In: CLIN CANCER RES. 12, 17, p. 5040-5046 17.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. 2005

  14. Elevated expression of Wnt antagonists is a common event in hepatoblastomas

    Koch, A., Waha, A., Hartmann, W., Hrychyk, A., Schüller, U., Waha, A., Wharton, K. A., Fuchs, S. Y., von Schweinitz, D. & Pietsch, T., 15.06.2005, In: CLIN CANCER RES. 11, 12, p. 4295-304 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells.

    Willipinski-Stapelfeldt, B., Riethdorf, S., Assmann, V., Woelfle, U., Rau, T., Sauter, G., Heukeshoven, J. & Pantel, K., 2005, In: CLIN CANCER RES. 11, 22, p. 8006-8014 22.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity.

    Müller, V., Stahmann, N., Riethdorf, S., Rau, T., Zabel, T., Goetz, A., Jänicke, F. & Pantel, K., 2005, In: CLIN CANCER RES. 11, 10, p. 3678-3685 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.

    Stams, U., Wendy, A. G., Den, B., Monique, L., Beverloo, U., Berna, H., Meijerink, U., Jules, P. P., Wering, V., Elisabeth, R., Janka-Schaub, G., Gritta, E., Pieters, U. & Rob, U., 2005, In: CLIN CANCER RES. 11, 8, p. 2974-2980 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. 2004

  19. Circulating growth factor levels are associated with tumorigenesis in neurofibromatosis type 1

    Mashour, G. A., Driever, P. H., Hartmann, M., Drissel, S. N., Zhang, T., Scharf, B., Felderhoff-Müser, U., Sakuma, S., Friedrich, R. E., Martuza, R. L., Mautner, V. F. & Kurtz, A., 01.09.2004, In: CLIN CANCER RES. 10, 17, p. 5677-83 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Antiangiogenic therapy by local intracerebral microinfusion improves treatment efficiency and survival in an orthotopic human glioblastoma model.

    Schmidt, N-O., Ziu, M., Carrabba, G., Giussani, C., Bello, L., Sun, Y., Schmidt, K., Albert, M., Black, P. M. & Carroll, R. S., 2004, In: CLIN CANCER RES. 10, 4, p. 1255-1262 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Characterization of effusion-infiltrating T cells: benign versus malignant effusions.

    Atanackovic, D., Block, A., de Weerth, A., Faltz, C., Hossfeld, D. K. & Hegewisch-Becker, S., 2004, In: CLIN CANCER RES. 10, 8, p. 2600-2608 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients.

    Friedrich, M., Weisenberger, D. J., Cheng, J. C., Chandrasoma, S., Siegmund, K. D., Gonzalgo, M. L., Toma, M. I., Huland, H., Yoo, C., Tsai, Y. C., Nichols, P. W., Bochner, B. H., Jones, P. A. & Liang, G., 2004, In: CLIN CANCER RES. 10, 22, p. 7457-7465 22.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells.

    Reimers, N., Zafrakas, K., Assmann, V., Egen, C., Riethdorf, L., Riethdorf, S., Berger, J., Ebel, S., Jänicke, F., Sauter, G. & Pantel, K., 2004, In: CLIN CANCER RES. 10, 10, p. 3422-3428 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. KIT (CD117)-positive breast cancers are infrequent and lack KIT gene mutations.

    Simon, R., Panussis, S., Maurer, R., Spichtin, H., Glatz, K., Tapia, C., Mirlacher, M., Rufle, A., Torhorst, J. & Sauter, G., 2004, In: CLIN CANCER RES. 10(1 Pt 1), p. 178-183

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. 2003

  26. Differential vascular and transcriptional responses to anti-vascular endothelial growth factor antibody in orthotopic human pancreatic cancer xenografts

    Bockhorn, M., Tsuzuki, Y., Xu, L., Frilling, A., Broelsch, C. E. & Fukumura, D., 15.09.2003, In: CLIN CANCER RES. 9, 11, p. 4221-6 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Effects of whole body hyperthermia (41.8 degrees C) on the frequency of tumor cells in the peripheral blood of patients with advanced malignancies.

    Hegewisch-Becker, S., Braun, K., Otte, M., Corovic, A., Atanackovic, D., Nierhaus, A., Hossfeld, D. K. & Pantel, K., 2003, In: CLIN CANCER RES. 9, 6, p. 2079-2084 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Levels of soluble vascular endothelial growth factor (VEGF) receptor 1 in astrocytic tumors and its relation to malignancy, vascularity, and VEGF-A.

    Lamszus, K., Ulbricht, U., Matschke, J., Brockmann, M. A., Fillbrandt, R. & Westphal, M., 2003, In: CLIN CANCER RES. 9, 4, p. 1399-1405 4.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy.

    Thurm, H., Ebel, S., Kentenich, C., Hemsen, A., Riethdorf, S., Coith, C., Wallwiener, D., Braun, S., Oberhoff, C., Jänicke, F. & Pantel, K., 2003, In: CLIN CANCER RES. 9, 7, p. 2598-2604 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. 2001

  31. Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer

    Schmalfeldt, B., Prechtel, D., Härting, K., Späthe, K., Rutke, S., Konik, E., Fridman, R., Berger, U., Schmitt, M., Kuhn, W. & Lengyel, E., 08.2001, In: CLIN CANCER RES. 7, 8, p. 2396-404 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. 1997

  33. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.

    Zander, A. R., Berger, C., Kröger, N., Stockshläder, M., Krüger, W., Horstmann, M., Grimm, J., Zeller, W., Kabisch, H., Erttmann, R., Schönrock, P., Kuse, R., Braumann, D., Illiger, H. J., Fiedler, W., de Witt, M., Hossfeld, K. D. & Weh, H. J., 1997, In: CLIN CANCER RES. 3(12 Pt 2), p. 2671-2675

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 Next